H.R. 3 would mutilate American biopharmaceutical development of innovative medicines that are tackling serious diseases.
Treat: Access Is Expanded for Quality, Affordable, and Private Health Coverage
The expansion of HRAs is expected to benefit more than 11 million employees and their families.
Price Controls for Dummies
Democrats should learn what price controls REALLY mean.
D.C. Soda Tax Could Give Taxpayers A Nasty Toothache
The D.C. City Council could approve one of the highest soda taxes in the nation. On October 7, 2019, D.C. Councilmember Brianne Nadeau (D-Ward 1) introduced the Healthy Beverage Choices Act, which would place a 1.5 cent-per-ounce excise tax on sweetened beverages. The tax would be the third highest in the country, after Seattle, Washington and […]
NIH Should Close Montana Facility to Pay for $1.3 Billion of Repairs
Current state of NIH facilities could undermine life saving research.
GAO: PBMs Gave Back Majority of Drug Rebates
PBMs provide a valuable service in delivering drug benefits to beneficiaries.
Hope Ahead for VA/DOD Interoperability
In 1982, the Department of Veterans Affairs (VA) and the Department of Defense (DOD) were charged by Congress to share patient information for servicemembers transitioning from DOD into the VA health care system. This transition process has been anything but seamless, with medical records being attached to gurneys each time a patient was moved, and […]
Is the Prescription Drug Pricing Reduction Act Another Obamacare?
For weeks, there was little information on what would be in the legislation since it was being discussed and written behind closed doors.
Drug Price Controls Push Innovation Out of the Picture
As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny. Rep. Lloyd Doggett’s (D-Texas) bill, H.R. 1046, the Medicare Negotiation and Competitive Licensing Act, was introduced on February 7, 2019 and has 126 cosponsors in the House. This legislation would […]
The American Medical Association’s Shaky Stance on Socialized Medicine
As the American Medical Association’s (AMA) shrinking membership tilts further and further to the left, real questions need to be asked about the organization’s influence over the Medicare for All debate. After the AMA resisted Medicare in 1966, roughly 70 percent of doctors were registered members of the group. During the Clinton era, the AMA […]